Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 1/20 | 0.41 |
| ▸ | QDPR | P09417 | 3/20 | 0.41 |
| ▸ | HTR2C | P28335 | 4/20 | 0.40 |
| ▸ | KHK | P50053 | 6/20 | 0.39 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL27134405 | 0.91 | P2RY14 (0.41) | P2RY14QDPRHTR2CKHKPDE3B | |
| SCHEMBL27007764 | 0.90 | QDPR (0.46) | QDPRHTR2CKHKSIGMAR1HSD11B1 | |
| Trifluoroacetic Acid SCHEMBL27126926 | 0.88 | ALOX5AP (0.41) | P2RY14QDPRHTR2CKHKPDE3B | |
| SCHEMBL27025885 | 0.88 | QDPR (0.48) | QDPRHTR2CKHKSIGMAR1TGFBR1 | |
| Trifluoroacetic Acid SCHEMBL30746006 | 0.88 | PDE3B (0.51) | P2RY14QDPRHTR2CKHKPDE3B | |
| SCHEMBL27026001 | 0.81 | HTR2C (0.44) | QDPRHTR2CKHKSIGMAR1TGFBR1 | |
| SCHEMBL27025891 | 0.81 | HTR2C (0.44) | QDPRHTR2CKHKPDE3BPDE3A | |
| Trifluoroacetic Acid SCHEMBL30745996 | 0.81 | WDR5 (0.43) | P2RY14HTR2CSOS1 | |
| SCHEMBL27007805 | 0.81 | PDE3B (0.53) | P2RY14QDPRHTR2CKHKPDE3B | |
| Trifluoroacetic Acid SCHEMBL30745977 | 0.80 | HSD11B1 (0.38) | P2RY14QDPRHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018121-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018121-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | ERG28, CYP51A1, MANBA | P2RY14 3799/4885QDPR 1183/4885HTR2C 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.